Coronavirus

Flu cases surge in the UK hospitals while China battles human metapneumovirus

Flu Season: New data from the NHS shows rapid rise in flu cases across the UK, whilst across the world, china continues its battle against human metapneumovirus virus.

Equine Assisted Interventions: Enhancing mental health and wellbeing

Ann Hemingway, Professor of Public Health at Bournemouth University, Dept Medical Science & Public Health, discusses how Equine Assisted Interventions can enhance mental health and wellbeing.

Diabetes patients are three times as likely to have severe COVID

While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.

Brexit and COVID anxieties create 25% drop in British exports

According to recent data analysis, Brexit and COVID anxieties have created tangible decreases in how many commodities leave the UK.

Infodemic: The other face of epidemics (COVID-19)

Dr Sylvie Briand, Director, Global Infectious Hazards Preparedness Department at the World Health Organization, explains how COVID-19 is accompanied by fighting an infodemic.

The circular economy: A recipe for success

Maria Nikolopoulou, Member of the European Economic and Social Committee, details why the circular economy is a recipe for success.

How can medical and safety technology manufacturers provide support during a pandemic?

Here, we look into the many ways in which medical and safety technology manufacturer Dräger has been stepping up to help its customers through the COVID-19 crisis.

How can Europe support its cultural recovery from COVID-19?

Open Access Government discovers how Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, is prioritising the recovery of Europe’s cultural sectors as well as Research and Innovation.

Why a reformed social care system in the UK cannot wait

Fiona Carragher, Director of Research and Influencing at Alzheimer’s Society walks us through why a reformed social care system in the UK cannot wait.

From COVID-19 to the future of public health surveillance

Andrea Ammon, Director at the European Centre for Disease Prevention and Control, takes us on a journey from COVID-19 to the future of public health surveillance.

Autonomous robots fight infections on the front lines

Per Juul Nielsen, CEO at UVD Robots, explains how autonomous robots can be used to fight infections, such as COVID-19 on the front lines.

Pfizer COVID-19 vaccine to be rolled out across UK next week

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and will be made available as early as next week.

We must find other ways to keep NHS teams safe when they can’t work from home

Dr Anas Nader, co-founder and CEO of Patchwork Health, discusses why we must find reliable ways to keep NHS teams safe when they can't work from home during the pandemic.

Selecting hand hygiene products in a global pandemic

Chris Wakefield, Vice President of GOJO Industries-Europe Ltd, explores how businesses can navigate the increase in cleaning products on the market and select products that will best meet their needs.

Exploring UVC technology for infection control

Anti Viral UVC explores how ultraviolet light works and how UVC energy is an effective and environmentally friendly way to eradicate dangerous microorganisms in any environment.

COVID-19 testing labs: Size isn’t everything

When it comes to COVID-19 testing labs, size isn’t everything, according to Alan Thornhill, UK Country Manager at Igenomix and Honorary Professor of Reproductive Genetics at the University of Kent, who spoke to Natalie Broome (MSc student, Kent).

The Moderna vaccine has a final efficiency of 94.1%

The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders